Antimicrobial Polymer Brush Coatings Without Antibiotic Resistance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional anti-infection surfaces using antibiotics or antibacterial agents risk promoting antimicrobial resistance, necessitating the development of coatings that can effectively inhibit bacterial growth.
Innovation Solution
The development of smart Polymer Brush Biocoatings (sPBBs) through a multi-step process involving inert plasma treatment, exposure to air, and ammonium monomer solution to create a polymer brush layer on biomaterials, which inhibits both adherent bacteria and biofilms without antibiotics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional anti-infection surfaces are loaded with antibiotics or antibacterial agents, then anti-infection capability is improved, but antimicrobial resistance is promoted
Solution Approach 1:
The patent extracts and eliminates antibiotics and antibacterial agents from the anti-infection surface formulation. Instead, it uses a polymer brush coating composed of inert or biocompatible polymers that provide anti-infection capability through physical mechanisms rather than chemical antibacterial action, thereby preventing antimicrobial resistance while maintaining reliability.
Solution Approach 2:
The patent changes the fundamental parameter of the anti-infection mechanism from chemical (antibiotics) to physical (polymer brush structure). The polymer brush coating creates a physical barrier and alters surface properties to prevent bacterial adhesion and biofilm formation, achieving anti-infection without the harmful side effects of antimicrobial agents.
2Manufacturing precision
If polymer brush coating process is extended to improve coating quality, then coating uniformity is improved, but processing time is increased
Solution Approach 1:
The patent performs preliminary plasma treatment of the substrate surface before applying the polymer brush coating. This preliminary action activates the substrate surface to enhance adhesion and ensures more uniform coating deposition, reducing the need for extended processing times while maintaining high coating quality and uniformity.
Solution Approach 2:
The patent uses a composite coating approach combining plasma-treated substrate with polymer brush coating. This composite structure achieves superior coating uniformity and adhesion through the synergistic effect of plasma activation and polymer brush deposition, optimizing both quality and processing efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
sPBBs demonstrate broad-spectrum activity against antibiotic-resistant bacteria, prevent biofilm formation, maintain biocompatibility, and remain stable over time, effectively killing bacteria and biofilms while ensuring compatibility with human tissues.
Implementation Method 1
applying an inert plasma directly to a biomaterial substrate for about 1-5 minutes at a discharge power of about 60-100 watts, thereby producing an activated biomaterial
Implementation Method 2
exposing the activated biomaterial to air for about 50 to about 100 minutes to generate hydroperoxide, hydroxyl, and/or peroxide reactive centers on the activated biomaterial
Implementation Method 3
placing the air-exposed activated biomaterial into an ammonium monomer solution with a concentration of about 20-50% (w/v) to induce graft polymerization to initiate a free-radical surface grafting at reactive centers
Data Source
AI summary
The present invention relates to methods of producing antimicrobial coatings on biomaterial substrates. The methods comprise: a) applying an inert plasma directly to a biomaterial substrate for about 1-5 minutes at a discharge power of about 60-100 watts, thereby producing an activated biomaterial, b) exposing the activated biomaterial to air for about 50 to about 100 minutes to generate hydroperoxide, hydroxyl, and/or peroxide reactive centers on the activated biomaterial, and c) placing the air-exposed activated biomaterial into an ammonium monomer solution with a concentration of about 20-50% (w/v) to induce graft polymerization, thereby initiating a free-radical surface grafting at reactive centers.